Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER + breast cancer

Cancer Research

Volumn 72, Issue 8, 2012, Pages 1935-1942

  Amon, Lynn M ^a   Pitteri, Sharon J ^c   Li, Christopher I ^a   McIntosh, Martin ^a   Ladd, Jon J ^a   Disis, Mary ^b   Porter, Peggy ^a   Wong, Chee Hong ^a   Zhang, Qing ^a   Lampe, Paul ^a   Prentice, Ross L ^a   Hanash, Samir M ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; GLYCOLYSIS PROTEIN; PLASMA PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CANCER DIAGNOSIS; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; GENE IDENTIFICATION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN SECRETION; UPREGULATION;

AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EARLY DETECTION OF CANCER; FEMALE; GLYCOLYSIS; HUMANS; MASS SPECTROMETRY; MIDDLE AGED; PROTEOMICS; RECEPTORS, ESTROGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84860168124     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-3266     Document Type: Article

References (41)

1. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography. A meta-analysis. JAMA 1995;273:149-54.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-49.
3. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials 1998;19:61-109.
4. Hanash SM, Pitteri SJ, Faca VM. Mining the plasma proteome for cancer biomarkers. Nature 2008;452:571-9. (Pubitemid 351483371)
5. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003;34:267-73. (Pubitemid 36792858)
6. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005;102:15545-50. (Pubitemid 41528093)
7. Tian L, Greenberg SA, Kong SW, Altschuler J, Kohane IS, Park PJ. Discovering statistically significant pathways in expression profiling studies. Proc Natl Acad Sci U S A 2005;102:13544-9. (Pubitemid 41420885)
8. Kim BS, Kim I, Lee S, Kim S, Rha SY, Chung HC. Statistical methods of translating microarray data into clinically relevant diagnostic information in colorectal cancer. Bioinformatics 2005;21:517-28. (Pubitemid 40310239)
9. Jiang Z, Gentleman R. Extensions to gene set enrichment. Bioinformatics 2007;23:306-13. (Pubitemid 46323152)
10. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008;40:499-507. (Pubitemid 351601215)
11. Cha S, Imielinski MB, Rejtar T, Richardson EA, Thakur D, Sgroi DC, et al. In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology. Mol Cell Proteomics 2010;9:2529-44.
12. Oh JJ, Taschereau EO, Koegel AK, Ginther CL, Rotow JK, Isfahani KZ, et al. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis. Lung Cancer 2010;70:253-62.
13. Choi J, Southworth LK, Sarin KY, Venteicher AS, Ma W, Chang W, et al. TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program. PLoS Genet 2008;4:e10.
14. Hays J, Hunt JR, Hubbell FA, Anderson GL, Limacher M, Allen C, et al. The Women's Health Initiative recruitment methods and results. Ann Epidemiol 2003;13:S18-77. (Pubitemid 37324176)
15. Pitteri SJ, Amon LM, Busald Buson T, Zhang Y, Johnson MM, Chin A, et al. Detection of elevated plasma levels of epidermal growth factor receptor before breast cancer diagnosis among hormone therapy users. Cancer Res 2010;70:8598-606.
16. Katayama H, Paczesny S, Prentice R, Aragaki A, Faca VM, Pitteri SJ, et al. Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings. Genome Med 2009;1:47.
17. Pitteri SJ, Hanash SM, Aragaki A, Amon LM, Chen L, Busald Buson T, et al. Postmenopausal estrogen and progestin effects on the serum proteome. Genome Med 2009;1:121.
18. Faca V, Coram M, Phanstiel D, Glukhova V, Zhang Q, Fitzgibbon M, et al. Quantitative analysis of acrylamide labeled serum proteins by LCMS/MS. J Proteome Res 2006;5:2009-18. (Pubitemid 44232714)
19. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 2002;74:5383-92. (Pubitemid 35215372)
20. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003;75:4646-58. (Pubitemid 37082259)
21. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004;3:Article3.
22. Broad Institute. Available from: www.broadinstitute.org.
23. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodological) 1995;57:289-300.
24. Warburg O. On the origin of cancer cells. Science 1956;123:309-14.
25. Toschi A, Lee E, Thompson S, Gadir N, Yellen P, Drain CM, et al. Phospholipase D-mTOR requirement for the Warburg effect in human cancer cells. Cancer Lett 2010;299:72-9.
26. Sun Q, Chen X, Ma J, Peng H, Wang F, Zha X, et al. Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth. Proc Natl Acad Sci U S A 2011;108:4129-34.
27. Rigo P, Paulus P, Kaschten BJ, Hustinx R, Bury T, Jerusalem G, et al. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 1996;23:1641-74.
28. Bi X, Lin Q, Foo TW, Joshi S, You T, Shen HM, et al. Proteomic analysis of colorectal cancer reveals alterations in metabolic pathways: mechanism of tumorigenesis. Mol Cell Proteomics 2006;5:1119-30. (Pubitemid 43985935)
29. Unwin RD, Craven RA, Harnden P, Hanrahan S, Totty N, Knowles M, et al. Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect. Proteomics 2003;3:1620-32. (Pubitemid 37048086)
30. Perroud B, Lee J, Valkova N, Dhirapong A, Lin PY, Fiehn O, et al. Pathway analysis of kidney cancer using proteomics and metabolic profiling. Mol Cancer 2006;5:64.
31. Isidoro A, Casado E, Redondo A, Acebo P, Espinosa E, Alonso AM, et al. Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis. Carcinogenesis 2005;26:2095-104. (Pubitemid 41672197)
32. Palaskas N, Larson SM, Schultz N, Komisopoulou E, Wong J, Rohle D, et al. 18F-Fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers. Cancer Res 2011;71:5164-74.
33. Corzett TH, Fodor IK, Choi MW, Walsworth VL, Turteltaub KW, McCutchen-Maloney SL, et al. Statistical analysis of variation in the human plasma proteome. J Biomed Biotechnol 2010;2010:258494.
34. Gong Y, Li X, Yang B, Ying W, Li D, Zhang Y, et al. Different immunoaffinity fractionation strategies to characterize the human plasma proteome. J Proteome Res 2006;5:1379-87. (Pubitemid 43865808)
35. Gundry RL, Fu Q, Jelinek CA, Van Eyk JE, Cotter RJ. Investigation of an albumin-enriched fraction of human serum and its albuminome. Proteomics Clin Appl 2007;1:73-88.
36. Migneco G, Whitaker-Menezes D, Chiavarina B, Castello-Cros R, Pavlides S, Pestell RG, et al. Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling. Cell Cycle 2010;9:2412-22.
37. Pavlou MP, Kulasingam V, Sauter ER, Kliethermes B, Diamandis EP. Nipple aspirate fluid proteome of healthy females and patients with breast cancer. Clin Chem 2010;56:848-55.
38. Koukourakis MI, Kontomanolis E, Giatromanolaki A, Sivridis E, Liberis V. Serum and tissue LDH levels in patients with breast/gynaecological cancer and benign diseases. Gynecol Obstet Invest 2009;67:162-8.
39. Seth LR, Kharb S, Kharb DP. Serum biochemical markers in carcinoma breast. Indian J Med Sci 2003;57:350-4. (Pubitemid 39663732)
40. Papaldo P, Di Cosimo S, Ferretti G, Vici P, Marolla P, Carlini P, et al. Effect of filgrastim on serum lactate dehydrogenase and alkaline phosphatase values in early breast cancer patients. Cancer Invest 2004;22:650-3. (Pubitemid 39506888)
41. Pitteri SJ, Faca VM, Kelly-Spratt KS, Kasarda AE, Wang H, Zhang Q, et al. Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells. J Proteome Res 2008;7:1481-9.